Week 3: DKA & HHS

Overview of Content

  • Fluid and Electrolyte Regulation

    • Define processes regulating the movement of water and electrolytes.

    • Describe etiology, diagnostic findings, clinical manifestations, and nursing management of associated disorders.

    • Identify acid-base balance maintenance processes.

    • Discuss associated acid-base imbalances.

    • Describe composition and indications of common IV fluid solutions.

    • Discuss types and nursing management of central venous access devices.

Fluid Types

  • Quick Review

    • Isotonic

      • Expands extracellular fluid (ECF) and intravascular space.

      • Examples: 0.9% Normal Saline (NSS), Lactated Ringer's Solution, D5W.

    • Hypotonic

      • Contains more water than electrolytes.

      • Causes movement of water from ECF to intracellular fluid (ICF).

      • Example: 0.45% NSS.

    • Hypertonic

      • Pulls fluid into ECF, increases blood pressure.

      • Risk of vascular fluid overload.

      • Examples: D5 0.45% NSS, D5 0.9% NSS, D10%, 3% NSS.

Fluid and Electrolytes

  • Dehydration

    • Defined as fluid loss leading to electrolyte concentration increase.

  • Hypovolemia

    • Represents loss of both fluids and electrolytes.

  • Fluid Retention

    • Describes a decrease in electrolyte concentration due to excess body fluid.

  • Hypervolemia

    • Characterized by increases in body fluids and sodium balance.

Electrolyte Disturbances

  • Causes of Electrolyte Increase

    • Retention, decreased excretion, excessive ingestion, fluid loss.

  • Causes of Electrolyte Decrease

    • Increased excretion, inadequate ingestion, fluid overload dilution.

  • Normal Ranges for Key Electrolytes

    • Potassium: 3.5-5.0 mEq/L

    • Phosphorous: 2.5-4.5 mg/dL

    • Sodium: 135-145 mEq/L

    • Calcium: 8.5-10.5 mg/dL

    • Magnesium: 1.8-3.0 mg/dL.

Administration of Potassium

  • Key Rules

    • Infusion: Never give IV push; always dilute.

      • Push is given to prison for deaath penalty.

    • Dosage: Administer 10-20 mEq per hour.

    • Sample order: 40 mEq KCL in 500 mL D5W over 4 hours.

    • Preference for central line administration.

Diabetes Overview

  • Pathophysiology

    • Affects carbohydrate, fat, and protein metabolism related to insulin and glucagon imbalances.

    • Both Type 1 and Type 2 diabetes are characterized by hyperglycemia.

    • These clients are very dehydrated.

      • The water is coming in and out because the glucose isn’t using it, thus this is why clients have polydipsia and polyuria.

Symptoms of Diabetes

  • Classic Symptoms

    • Polydipsia (excessive thirst)

    • Polyuria (increased urination)

    • Polyphagia (increased hunger) due to alternative energy utilization (fat, then protein) when glucose is unavailable.

Type 1 Diabetes Characteristics

  • Accounts for <10% of all diabetics.

    • Autoimmune disease with viral triggers is primarily diagnosed in children and young adults.

    • Abrupt onset with weight loss; presence of urine ketones; no endogenous insulin production.

      • Glycolysis: the metabolic pathway that converts glucose into pyruvate, producing ATP and NADH, plays a crucial role in energy metabolism, particularly under conditions of insulin deficiency common in DKA.

      • Proteinloysis: The breakdown of proteins into amino acids occurs, leading to further metabolic complications in patients.

        • Both contribute to ketones in urine.

Type 2 Diabetes Characteristics

  • Most prevalent type (80-90% of diabetics).

    • Strong genetic component, often linked to obesity, predominantly occurs after age 45 (most common over age 65).

    • Insidious onset; insulin resistance developed; ketoacidosis is not typical.

Insulin Types and Their Characteristics

  • Rapid-acting

    • Onset: 5-15 min

    • Peak: 45-75 min

    • Duration: 2-4 hrs

    • Used for meals or acute hyperglycemia.

  • Short-acting (Regular; given in DKA)

    • Onset: 30-60 min

    • Peak: 2-4 hrs

    • Duration: 5-8 hrs

    • Used for meals or acute hyperglycemia.

  • Intermediate-acting

    • Onset: 1-2 hrs

    • Peak: 4-12 hrs

    • Duration: 18-24 hrs.

  • Long-acting (Glargine)

    • Onset: 2 hrs

    • No peak

    • Duration: 24 hrs.

  • Long-acting (Detemir)

    • Onset: 2 hrs

    • Peak: 3-9 hrs

    • Duration: 6-24 hrs.

Diabetic Ketoacidosis (DKA)

  • Acute Complication of Uncontrolled Diabetes

    • Fatal if left untreated.

    • Characterized by hyperglycemia, dehydration, electrolyte loss (K+ and Na), hyperkalemia, ketosis, and metabolic acidosis (only in DKA).

DKA Etiology and Pathophysiology

  • Primary Clinical Features

    • Presence of hyperglycemia, dehydration, hyperkalemia, ketosis, and metabolic acidosis.

Clinical Manifestations of DKA

  • Symptoms can be nonspecific and mistaken for other conditions:

    • Flushed, warm, and dry skin.

    • Lethargy and decreased level of consciousness (LOC).

    • Blurred vision.

    • Hypotension and tachycardia.

    • Severe abdominal pain, nausea, vomiting (GI upset with DKA due to the glycolysis going on).

    • Polyuria and polydipsia occurred 1-3 days prior.

    • Hyperventilation with Kussmaul respirations and fruity odor on breath (related to compensation for metabolic acidosis).

DKA Laboratory Findings

  • Serum glucose: 250-600 mg/dL

  • Serum potassium: can be high, low, or normal

  • Blood pH: 6.8-7.3

    • Give bicarbonate (IV push or drip) if the pH is less than 7.

  • Serum bicarbonate: <15 mEq/L

  • Serum sodium: 130-140 mEq/L

  • BUN: mildly elevated

  • Serum and urine ketones: increased.

Anion Gap Metabolic Acidosis

  • Definition:

    • Serum anion gap is determined using the formula:

      • Serum sodium - (serum chloride + bicarbonate).

    • In DKA, the anion gap may be higher than 20 mEq/mL.

    • Normal is between 3-10.

      • Anything over 12 is considered a gap; consider metabolic acidosis.

Goals of DKA Management

  1. Correct fluid and electrolyte imbalances

  2. Provide adequate insulin for glucose metabolism

  3. Correct acidosis

  4. Prevent complications

Goal #1: Correct Fluid and Electrolyte Imbalances
  • Initial IV fluid replacement with normal saline (NS) at a rate of 1 liter/hour until blood pressure stabilizes and urine output > 60 mL/hour.

    • May get 1 or more liters based on lab values.

  • After the first liter, switch to half normal saline at 300-500 mL/hour until glucose levels decrease.

  • When glucose is <250, change to D5 0.45% saline (hypertonic) to ensure continued insulin administration without hypoglycemia.

    • Once until <200-180, then the client can start eating and drinking.

Potassium Monitoring in DKA
  • Potassium levels: Initial high values expected due to movement out of cells.

  • Monitor serum K+ frequently post-hydration and insulin therapy initiation as levels can decline.

Goal #2: Provide Adequate Insulin
  • Initial IV bolus: 0.15 units/kg, followed by continuous infusion at 0.1 units/kg.

  • Monitor blood glucose every hour; if no change after 1 hr, double the infusion rate.

    • Prevent a decrease in glucose by more than 50-100 mg/hour to avoid complications such as cerebral edema.

  • Upon blood glucose <250 mg/dL, reduce insulin infusion by half and switch to sliding scale therapy.

    • Sliding scale while still on the drip to prevent rebound hyperglycemia and maintain stable glucose levels.

Goal #3: Correct Acidosis
  • Routine bicarbonate administration is not advised; acidosis resolves with insulin’s action.

  • If pH < 7.0, a slow IV infusion of bicarbonate may be given over several hours.

Goal #4: Prevent Complications
  • Monitor and promptly address:

    • Cardiac arrhythmias.

    • Electrolyte imbalances (hyper/hypokalemia).

    • Cerebral and pulmonary edema.

    • Hypoglycemia.

    • Acute renal failure.

Patient Teaching for DKA

  • Emphasize adherence to treatment regimens, especially during illness:

    • Do not stop insulin/hypoglycemic agents when sick (sick day rules).

      • Prioritizing hydration and checking sugar more often.

    • Maintain oral intake of fluids and carbohydrates.

    • Check blood glucose and ketones every 4 hours.

    • Contact healthcare provider if unable to take PO or if urine ketones are positive or BG is elevated.

Hyperglycemic Hyperosmolar Syndrome (HHS)

  • Higher mortality rate than DKA (20-40%).

  • Gradual onset over days to weeks (DKA occurs within a few hours).

  • Hallmarks: Severe hyperglycemia, profound dehydration, and lack of ketosis.

    • No change in pH.

    • Occurs more likely in Type 2, especially in those who don’t drink water.

HHS Etiology and Pathophysiology

  • More common in type II diabetics, frequently triggered by illness or stress.

  • Most prevalent in older, obese diabetics with impaired thirst and decreased renal function.

  • May also occur in patients previously undiagnosed with diabetes, sometimes precipitated by medications like steroids or thiazides.

What's Happening in HHS?

  • Major differentiation from DKA: No ketonuria, as the patient retains some insulin secretion.

  • Despite insulin secretion, glucose transport into cells is inadequate, leading to hyperglycemia.

HHS Clinical Manifestations

  • Gradual symptom onset (you’d notice more signs of dehydration):

    • Polydipsia, polyuria, sugar cravings.

    • Weight loss, dry mucous membranes, poor skin turgor, pallor.

    • Weakness, fatigue, lethargy, coma.

    • Hypotension, tachycardia.

    • Dyspnea without fruity breath.

    • Mild abdominal pain.

HHS Laboratory Findings

  • Serum glucose: 600-2000 mg/dL.

  • Serum ketones: normal or mildly elevated.

  • Serum pH: normal or mild acidosis (pH > 7.25).

  • Serum Na+: normal or elevated.

  • Bicarbonate: normal.

  • Serum K+: normal, low, or elevated.

  • BUN: >80 mg/dL.

    • Higher chance of kidney injury due to fluid imbalances.

  • Serum osmolality: >400 (normal 285-295).

Nursing Care for HHS

  • Primary Intervention: Rapid rehydration, with deficits potentially exceeding 10 liters.

    • Administer NS 2L during the first hour, followed by D5 0.45% saline for the next 6-10L.

    • When glucose reaches 250-300 mg/dL, switch to D5 1/2 NS.

IV Insulin Administration in HHS
  • Low-dose insulin to facilitate cellular glucose uptake and decrease serum osmolality.

  • Potassium Replacement: Needed as rehydration occurs; however, loss is generally less than in DKA.

  • Bicarbonate therapy is not necessary in HHS management.

Comparison between DKA and HHS

  • Patients Affected:

    • DKA: Type 1 diabetes (can also occur with Type 2).

    • HHS: Type 2 diabetes, especially in the elderly.

  • Precipitating Events:

    • DKA: Omission of insulin or stress (infection, surgery, stroke, MI).

    • HHS: Physiologic stressors.

  • Onset:

    • DKA: Rapid (less than 24 hours).

    • HHS: Slower (days).

  • Blood Glucose Levels:

    • DKA: Usually over 250 mg/dL.

    • HHS: Usually over 600 mg/dL.

  • Arterial pH Level:

    • DKA: Below 7.3

    • HHS: Typically normal.

  • Serum and Urine Ketones:

    • DKA: Present

    • HHS: Absent.

  • Serum Osmolality:

    • DKA: 300-350 mOsm/L

    • HHS: Greater than 350 mOsm/L.

  • Plasma Bicarbonate Level:

    • DKA: Less than 15 mEq/L

    • HHS: Normal.

  • BUN and Creatinine Levels:

    • Both conditions are elevated.

  • Mortality Rate:

    • DKA: Less than 5%

    • HHS: 10-40%.